20,000 shareholders were awakened by thunder! The 12 billion richest person can only give more than 3 million

category:Finance
 20,000 shareholders were awakened by thunder! The 12 billion richest person can only give more than 3 million


Furen Pharmaceutical Co., Ltd. pointed out in response to the Shanghai Stock Exchange inquiry that as of July 19, the company and its subsidiaries had a total cash value of 127 million yuan, of which 123 million yuan was limited and 37.77 million yuan was unrestricted.

For more than 20,000 shareholders of Furen Pharmaceutical Co., Ltd., the truth revealed by Furen Pharmaceutical Co., Ltd. is like a thunderbolt from the blue sky. The investors are worried that the once capital-sought medical white horse stock is the next Kangmei Pharmaceutical Co., Ltd.

Steady and steady progress: the second Kangmei, ah, fortunately, buy less.

Niu Niu Rolling Snowball: Money, like Swertia Island, scallops run away.

Dragon in the river and lake drift 2: Another big fraud subsidiary.

Hongze Capital: False financial report, no money to say that there is money, lure more people into the field and bury them alive, start counting boards!

The fuse has to start six days ago.

Furen Pharmaceutical was originally scheduled to register its shares on July 19 and complete the cash dividend payment on July 22. But strangely, Furen Pharmaceutical announced in the afternoon of July 19 that it had not completed the transfer of cash dividend and could not pay out the cash according to the original plan.

In recent years, Furen Pharmaceutical Companys revenue and profit have been increasing steadily. From 2016 to 2018, Furen Pharmaceutical Company has realized 5.01 billion yuan, 5.8 billion yuan and 6.32 billion yuan of business income respectively. The non-net profit deducted by shareholders of listed companies is 350 million yuan, 390 million yuan and 89 million yuan respectively.

In the first quarter of 2019, the company continued to grow steadily, with revenue of 1.37 billion yuan, an increase of 1.02% over the same period last year. Shareholders of listed companies deducted non-net profit of 190 million yuan, an increase of 15.19% over the same period last year.

As of March 31, 2019, Furen Pharmaceutical Company had 1.816 billion yuan in money. That is to say, the company has 1.8 billion dollars on its books, but it cant give 60 million dividends to shareholders.

A stone stirs up a thousand waves.

As early as 2016, Furen Pharmaceutical Industry was reported to be suspected of financial fraud.

According to the informer, there were significant financial fraudulent acts when Kaiyao Group injected Furen Pharmaceutical Trading. Kaiyao Group is suspected of falsely increasing net assets by 1.7 billion yuan and falsely reporting profits by 1.4 billion yuan. Kaiyao Group has evaded income tax by 1 billion yuan and Furen Group has evaded tax by at least 2 billion yuan.

At the end of the first quarter, the actual funds and the changes and flows of funds up to now still need further verification. The company will conduct in-depth self-examination and announce in time after verification. On July 24, Furen Pharmaceutical Company issued the above announcement.

Financial difficulties, Furen Pharmaceutical Co., Ltd. on the Lao Lai blacklist

The financial crisis of Furen Pharmaceutical Industry began as early as last June. According to media reports at that time, Furen Pharmaceutical Industry was facing a predicament of 391 million tail money in the transaction of 7.8 billion yuan merger and acquisition of Kaidu Pharmaceutical Group.

Since this year, frequent equity freezes and judicial disputes have exposed the liquidity difficulties of Furen Pharmaceutical Industry.

Looking at the announcement of Furen Pharmaceutical Industry, we can find that since June, the company has issued a total of 12 announcements on the freezing of controlling shareholdersshares. Furen Pharmaceutical Group holds Furen Pharmaceutical Shares, which are partly or completely frozen by the Peoples Court of Zhengzhou High-tech Industrial Development Zone in Henan Province, Zhoukou Intermediate Peoples Court in Henan Province, and the Peoples Court of Hengqin New District in Zhuhai, Guangdong Province.

Furen Pharmaceutical announced on July 28 that up to now, the controlling shareholder of the company, Furen Pharmaceutical Group, has frozen 282 million shares, accounting for 45.03% of the companys total equity and 100% of the companys shares held by Furen Group.

Meanwhile, since May 9, 2019, Furen Pharmaceutical Industry has been listed as the executed person six times in more than three months, with a total execution target of 102 million yuan, including in a private lending lawsuit, the company is co-located with Furen Group and Zhu Wenchen as the defendant.

According to the Securities Times, there are many enterprises under the subsidiary of Furen Pharmaceutical Group, including Furen Pharmaceutical Company and its parent company, which often suffer from stoppage and salary arrears. Furen Pharmaceutical Bulletin said that the companys current shortage of funds may lead to insufficient capacity, which may affect the sales of related products.

Suspected Occupation of Listed CompaniesFunds

According to public data, Furen Group and its co-actors hold 306 million shares in Furen Pharmaceutical Industry, accounting for 48.94% of its total share capital. The actual control of Furen Pharmaceutical Industry is Zhu Wenchen.

After the backdoor listing of Furen Pharmaceutical Industry, Zhu Wenchens wealth soared. He ranked the richest man in Henan Province with 7.6 billion yuan and 8 billion yuan in 2012 and 2013 respectively. According to the 2008 Hurun 100 Rich List, Zhu Wenchens family reached 12 billion yuan.

At the same time, Songhe distillery is also in arrears of employeessalaries.

Furen Pharmaceutical Industry announced on July 24 that on January 11, 2018, Songhe Industry entrusted Zhengzhou Agricultural Guarantee Company to provide guarantee for financing and borrowing of its North Ring Road Branch of Zhengzhou Bank, and signed a Entrusted Guarantee Contract with Zhengzhou Agricultural Guarantee Company, which stipulated that Zhu Wenchen, Furen Group and Furen Pharmaceutical Industry should provide guarantee to Zhengzhou Agricultural Industry. Guarantee companies provide counter-guarantees. Based on the guarantee of Zhengzhou Agricultural Guarantee Company, Zhengzhou Bank and Songhe Liquor Industry signed the Liquidity Loan Contract with the amount of 30 million yuan. The loan period is from January 12, 2018 to January 4, 2019. The above guarantee amount accounted for 0.56% of the companys net assets at the end of 2018. However, the above guarantees were not disclosed in time or through the internal decision-making process of Furen Pharmaceutical Industry. Large shareholders suspected of misappropriating funds of listed companies is the markets challenge to Furen Pharmaceutical Industry. The inquiry letter of the Shanghai Stock Exchange also requires Furen Pharmaceutical Industry to verify and explain the capital exchanges and guarantees with controlling shareholders, actual controllers and their affiliates, and whether there are funds occupation and irregular guarantees. As required by the Shanghai Stock Exchange, Furen Group and Zhu Wenchen should fully verify whether there are any cases of illegal occupation of company funds, requiring companies to provide guarantees, etc. to encroach on the interests of listed companies. Source: Daily Economic News Responsible Editor: Yang Bin_NF4368

Furen Pharmaceutical Industry announced on July 24 that on January 11, 2018, Songhe Industry entrusted Zhengzhou Agricultural Guarantee Company to provide guarantee for financing and borrowing of its North Ring Road Branch of Zhengzhou Bank, and signed a Entrusted Guarantee Contract with Zhengzhou Agricultural Guarantee Company, which stipulated that Zhu Wenchen, Furen Group and Furen Pharmaceutical Industry should provide guarantee to Zhengzhou Agricultural Industry. Guarantee companies provide counter-guarantees. Based on the guarantee of Zhengzhou Agricultural Guarantee Company, Zhengzhou Bank and Songhe Liquor Industry signed the Liquidity Loan Contract with the amount of 30 million yuan. The loan period is from January 12, 2018 to January 4, 2019. The above guarantee amount accounted for 0.56% of the companys net assets at the end of 2018.

Large shareholders suspected of misappropriating funds of listed companies is the markets challenge to Furen Pharmaceutical Industry. The inquiry letter of the Shanghai Stock Exchange also requires Furen Pharmaceutical Industry to verify and explain the capital exchanges and guarantees with controlling shareholders, actual controllers and their affiliates, and whether there are funds occupation and irregular guarantees.